Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Milena Todorovic-Balint"'
Autor:
Mirjana Mitrovic, Nikola Pantic, Zoran Bukumiric, Nikica Sabljic, Marijana Virijevic, Zlatko Pravdic, Mirjana Cvetkovic, Nikola Ilic, Jovan Rajic, Milena Todorovic-Balint, Ana Vidovic, Nada Suvajdzic-Vukovic, Jecko Thachil, Darko Antic
Publikováno v:
Thrombosis Journal, Vol 22, Iss 1, Pp 1-10 (2024)
Abstract Background Patients with acute myeloid leukemia (AML) are at increased risk of venous thromboembolic events (VTE). However, thromboprophylaxis is largely underused. Objectives This study aimed to determine possible VTE development risk facto
Externí odkaz:
https://doaj.org/article/5779e741e8a04875bbfd4e5dfe760715
Autor:
Tamara Vasiljevic, Marko Jankovic, Ana Tomic, Ida Bakrac, Stefan Radenovic, Danijela Miljanovic, Aleksandra Knezevic, Tanja Jovanovic, Irena Djunic, Milena Todorovic-Balint
Publikováno v:
Pharmaceuticals, Vol 17, Iss 4, p 428 (2024)
Introduction: Cytomegalovirus (CMV) infection is a major clinical issue after allogeneic hematopoietic stem cell transplantation (HSCT). The CMV envelope glycoproteins are key in viral pathogenesis; the glycoprotein B (gB) encoded by the UL55 gene mi
Externí odkaz:
https://doaj.org/article/1c3d7266b7604321942a9a5c7339b96d
Autor:
Marko Jankovic, Tara Knezevic, Ana Tomic, Ognjen Milicevic, Tanja Jovanovic, Irena Djunic, Biljana Mihaljevic, Aleksandra Knezevic, Milena Todorovic-Balint
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 7, p 3741 (2024)
The oncogenicity of the human cytomegalovirus (CMV) is currently being widely debated. Most recently, mounting clinical evidence suggests an anti-cancer effect via CMV-induced T cell-mediated tumor destruction. However, the data were mostly obtained
Externí odkaz:
https://doaj.org/article/143d67256a11414c94ffdfe1dd0bb500
Autor:
Aleksandra Sretenovic, Marko Mitrovic, Nikola Vukosavljevic, Zoran Bukumiric, Natalija Kecman, Milena Todorovic Balint, Jelica Jovanovic, Jelena Bila
Publikováno v:
HemaSphere, Vol 7, p e78893db (2023)
Externí odkaz:
https://doaj.org/article/9e936e19c61941febe7ffd8bdbb589f1
Autor:
Mihailo Smiljanic, Milena Todorovic Balint, Danijela Lekovic, Darko Antic, Biljana Mihaljevic
Publikováno v:
HemaSphere, Vol 7, p e78591ae (2023)
Externí odkaz:
https://doaj.org/article/1b56edf8194649e284d23128d94031dc
Autor:
Antic, Mirjana Mitrovic, Nikola Pantic, Nikica Sabljic, Zoran Bukumiric, Marijana Virijevic, Zlatko Pravdic, Mirjana Cvetkovic, Jovan Rajic, Jelena Bodrozic, Violeta Milosevic, Milena Todorovic-Balint, Ana Vidovic, Nada Suvajdzic-Vukovic, Darko
Publikováno v:
Cancers; Volume 15; Issue 11; Pages: 3060
Background: Patients with hematological malignancies have an increased risk of arterial thrombotic events (ATEs) after diagnosis, compared to matched controls without cancer. However, data about incidence and risk factors for ATE development in patie
Autor:
Biljana Mihaljevic, Mihailo Smiljanic, Darko Antic, Nada Kraguljac Kurtovic, Milena Todorovic Balint
Publikováno v:
Annals of Indian Academy of Neurology, Vol 21, Iss 1, Pp 85-87 (2018)
Externí odkaz:
https://doaj.org/article/66e2d3eea7df4f7cab1894bce1c32569
Autor:
Milena Todorovic-Balint, Bela Balint, Irena Djunic, Nevena Besevic, Andrej Pesic, Oliver Stojkovic
Publikováno v:
Medical review. 75:45-49
Introduction. Poor graft function is one of the most severe complications after allogeneic hematopoietic stem cell transplantation, which manifests as pancytopenia/cytopenia in the blood count, with the presence of complete or incomplete donor chimer
Autor:
Marija Elez, Milena Todorovic-Balint
Publikováno v:
Medical review. 75:54-56
Introduction. Modern treatment of Hodgkin?s lymphoma has led to a cure in 60-90% of patients. The problem are patients in whom disease relapse occurs, or the disease is refractory to initial therapy. The standard relapse treatment is the application
Publikováno v:
Medicinska rec. 1:109-113
There are four stem cell (SC) transplant centers in Serbia that carry out their activities within the European Group for Blood and Marrow Transplantation (EBMT). They are positioned in the Clinical Center of Serbia, Military Medical Academy, Institut